United Gulf Bank (B.S.C.)

◆英語タイトル:United Gulf Bank (B.S.C.) - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3227
◆発行会社(調査会社):MarketLine
◆発行日:2019
◆ページ数:36
◆レポート言語:
◆レポート形式:PDF
◆納品方法:E
◆対象地域:
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site LicenseUSD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide LicenseUSD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

United Gulf Bank (B.S.C.) – Strategy, SWOT and Corporate Finance Report
Summary

United Gulf Bank (B.S.C.) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

United Gulf Bank (B.S.C.) (UGB), a subsidiary of United Gulf Holding Company BSC, is a banking and financial services provider. The bank, along with its subsidiaries, provides a range of commercial and investment banking, and asset management solutions to corporate and institutional customers. Its portfolio of commercial banking products and services includes deposits, current accounts, loans and credit facilities, savings and pensions, financial brokerage and treasury services. The bank offers various investment banking solutions, including corporate finance, investments in quoted and private equities, capital market services, advisory services, equity and debt underwriting, capital restructuring, merchant banking and international banking. It also provides asset and fund management products and services comprising securities trading, mutual funds, and alternative or structured investments. The bank’s operations are spanned across Bahrain, Kuwait, Tunisia, British Virgin Islands, the US, and Jersey. UGB is headquartered at Manama, Bahrain.

Scope

- Detailed information on United Gulf Bank (B.S.C.) required for business and competitor intelligence needs
- A study of the major internal and external factors affecting United Gulf Bank (B.S.C.) in the form of a SWOT analysis
- An in-depth view of the business model of United Gulf Bank (B.S.C.) including a breakdown and examination of key business segments
- Intelligence on United Gulf Bank (B.S.C.)’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about United Gulf Bank (B.S.C.), such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of United Gulf Bank (B.S.C.) and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess United Gulf Bank (B.S.C.) as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on United Gulf Bank (B.S.C.)’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
United Gulf Bank (B.S.C.): Company Overview
United Gulf Bank (B.S.C.): Overview and Key Facts
United Gulf Bank (B.S.C.): Overview
United Gulf Bank (B.S.C.): Key Facts
United Gulf Bank (B.S.C.): Key Employees
United Gulf Bank (B.S.C.): Key Employee Biographies
United Gulf Bank (B.S.C.): Major Products and Services
United Gulf Bank (B.S.C.): Company History
United Gulf Bank (B.S.C.): Management Statement
United Gulf Bank (B.S.C.): Locations and Subsidiaries
United Gulf Bank (B.S.C.): Key Competitors
United Gulf Bank (B.S.C.): Company Analysis
United Gulf Bank (B.S.C.): Business Description
United Gulf Bank (B.S.C.): SWOT Analysis
United Gulf Bank (B.S.C.): SWOT Overview
United Gulf Bank (B.S.C.): Strengths
United Gulf Bank (B.S.C.): Weaknesses
United Gulf Bank (B.S.C.): Opportunities
United Gulf Bank (B.S.C.): Threats
United Gulf Bank (B.S.C.): Corporate Financial Deals Activity
United Gulf Bank (B.S.C.): Financial Deals Overview
United Gulf Bank (B.S.C.): Targets and Partners
United Gulf Bank (B.S.C.): Top Deals 2015 – 2019YTD*
United Gulf Bank (B.S.C.): Advisors
United Gulf Bank (B.S.C.): Top Legal Advisors
United Gulf Bank (B.S.C.): Mergers and Acquisitions
United Gulf Bank (B.S.C.): Recent Developments
United Gulf Bank (B.S.C.): News and Events Summary
United Gulf Bank (B.S.C.): Corporate Governance
United Gulf Bank (B.S.C.): Financial Performance
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: United Gulf Bank (B.S.C.): Key Facts
Table 2: United Gulf Bank (B.S.C.): Key Employees
Table 3: United Gulf Bank (B.S.C.): Company History
Table 4: United Gulf Bank (B.S.C.): Locations and Subsidiaries
Table 5: United Gulf Bank (B.S.C.): Key Competitors
Table 6: United Gulf Bank (B.S.C.): Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: United Gulf Bank (B.S.C.): Targets and Partners
Table 8: United Gulf Bank (B.S.C.): Top Deals 2015 - 2019YTD*
Table 9: United Gulf Bank (B.S.C.): Legal Advisor Ranking by Value (US$m)
Table 10: United Gulf Bank (B.S.C.): M&A Volume and Value Trend (2015 - YTD*2019)
Table 11: United Gulf Bank (B.S.C.): M&A Activity by Geography (2015 - YTD*2019)
Table 12: United Gulf Bank (B.S.C.): News and Events Summary
Table 13: United Gulf Bank (B.S.C.): Corporate Governance
Table 14: United Gulf Bank (B.S.C.): Financial Performance

★海外企業調査レポート[United Gulf Bank (B.S.C.)]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SBI Biotech Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary SBI Biotech Co Ltd (SBI), a subsidiary of SBI Holdings Inc, is a developer of molecule targeting drugs and immune modulation drugs. The company develops DNA nucleotide drugs targeting TLR and antibody drugs targeting dendritic cells. Its pipeline products include ILT7, SBI-9674, SBI-3150, GN …
  • Raytheon Co:企業のM&A・事業提携・投資動向
    Raytheon Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Raytheon Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Axpo Holding AG:企業の戦略的SWOT分析
    Axpo Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Teva Pharmaceutical Industries Ltd (TEVA)-製薬・医療分野:企業M&A・提携分析
    Summary Teva Pharmaceutical Industries Ltd (Teva) carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines in central nervous system (CNS), respiratory, cancer, women’s health and other therapy areas. The company off …
  • Aerostar S.A.:企業の戦略・SWOT・財務情報
    Aerostar S.A. - Strategy, SWOT and Corporate Finance Report Summary Aerostar S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Warner Media LLC.:企業の戦略・SWOT・財務分析
    Warner Media LLC. - Strategy, SWOT and Corporate Finance Report Summary Warner Media LLC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Royal DSM NV (DSM)-エネルギー分野:企業M&A・提携分析
    Summary Royal DSM NV (DSM) is a life sciences and materials sciences company, which focuses on health, nutrition and materials sectors. The company offers a wide range of products such as anti-invectives, polyesters, vitamins and other ingredients, performance materials to diverse end markets. It pr …
  • Idaho Power Co:企業の戦略的SWOT分析
    Idaho Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Ergomed Plc (ERGO):製薬・医療:M&Aディール及び事業提携情報
    Summary Ergomed Plc (Ergomed), formerly Ergomed Clinical Research Ltd is a drug development and clinical research services provider. The company provides service portfolio such as regulatory and quality management, biostatistics, study management, clinical data management, medical writing, and other …
  • Urban One, Inc.:企業の戦略・SWOT・財務分析
    Urban One, Inc. - Strategy, SWOT and Corporate Finance Report Summary Urban One, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Agfa-Gevaert N.V.:戦略・SWOT・企業財務分析
    Agfa-Gevaert N.V. - Strategy, SWOT and Corporate Finance Report Summary Agfa-Gevaert N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Arkema SA:企業の戦略・SWOT・財務分析
    Arkema SA - Strategy, SWOT and Corporate Finance Report Summary Arkema SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • PharmAust Ltd (PAA):企業の財務・戦略的SWOT分析
    Summary PharmAust Ltd (PAA) is a clinical-stage company that focuses on the development of targeted cancer therapeutics for the treatment of human and veterinary cancers. The company’s lead product candidate Monepantel is a small molecule that has been developed to treat parasite infections in food …
  • University of Wisconsin Madison-製薬・医療分野:企業M&A・提携分析
    Summary University of Wisconsin Madison (UW-Madison), a subsidiary of University of Wisconsin System is an educational and research institution that provides undergraduate and postgraduate courses. The institution offers courses in various fields such as agricultural and life sciences, arts, busines …
  • Michigan Public Power Agency:企業の発電所・SWOT分析2018
    Michigan Public Power Agency - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Cineworld Group Plc:企業の戦略・SWOT・財務分析
    Cineworld Group Plc - Strategy, SWOT and Corporate Finance Report Summary Cineworld Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Pharmaceutics International Inc-製薬・医療分野:企業M&A・提携分析
    Summary Pharmaceutics International Inc (PII) is a contract development and manufacturing company that offers dosage form development and cGMP manufacturing services. The company offers manufacturing of drugs such as dosage forms of solid, semi-solid, liquid, inhalation, parenteral and aseptic filli …
  • EDF Energy Holdings Ltd:企業の戦略的SWOT分析
    EDF Energy Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Galapagos NV (GLPG):企業の財務・戦略的SWOT分析
    Summary Galapagos NV (Galapagos) is a biotechnology company that discovers and develops small molecule medicines for the treatment of inflammatory and fibrotic diseases. It offers Filgotinib medication targeting rheumatoid arthritis (RA). The company is investigating GLPG3667 compound against autoim …
  • Banco Bilbao Vizcaya Argentaria Colombia SA:企業の戦略・SWOT・財務分析
    Banco Bilbao Vizcaya Argentaria Colombia SA - Strategy, SWOT and Corporate Finance Report Summary Banco Bilbao Vizcaya Argentaria Colombia SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆